Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
357,200,222
-
Share change
-
-17,500,852
-
Total reported value
-
$23,960,310,643
-
Put/Call ratio
-
104%
-
Price per share
-
$67.04
-
Number of holders
-
871
-
Value change
-
-$1,530,910,004
-
Number of buys
-
412
-
Number of sells
-
539
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2024
As of 30 Sep 2024,
DEXCOM INC - Common Stock (DXCM) was held by
871 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
357,200,222 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., Capital Research Global Investors, STATE STREET CORP, BAILLIE GIFFORD & CO, SANDS CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, Capital World Investors, and JENNISON ASSOCIATES LLC.
This page lists
871
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.